News

Filter by year   :   

Patents

Excluding GMOs/NGTs from patentability would be an illusion

On 7 February 2024, the European Parliament proposed to make a distinction between products derived from NGTs, such as plants, their parts and the genetic information they contain, which would be excluded from patentability, and NGT processes for obtaining these products, which would not be excluded. However, this decision could not be adopted in the […]

Biodiversité cultivée

Seed marketing reform: freeing cultivated biodiversity or patented GMOs?

While the proposed deregulation of GMOs is attracting a certain amount of attention, a proposal for a regulation on the marketing of seeds and other plant reproductive material is also being discussed in Brussels, albeit on a much more confidential basis. To shed light on what is at stake in these discussions, Inf’OGM is publishing […]

Patents

GMOs/NGTs : a deceptive patent ban

Since its publication on 5 July 2023, the European Commission’s regulatory proposal on “new genomic techniques” (NGTs) has been the subject of a complex and intense debate. A number of problems have been raised, such as the lack of a scientific basis, the proposed abolition of traceability for GMOs derived from these techniques, the abolition […]

Contamination

Problems ahead due to cultivation of GMO maize in Europe?

At the beginning of January 2023, the Anses published its comments on the environmental monitoring report on the cultivation of transgenic maize Mon810 in Spain and Portugal in 2021. Authorised for cultivation in the European Union since 1998, Mon810 transgenic maize produced by Bayer (since its acquisition of Monsanto) is subject to annual environmental monitoring […]

Lobby / conflict of interest

Few micro-organisms modified by Crispr are already on the market

There are eleven bacteria, 22 yeasts, one endophytic fungus (living symbiotically inside plants) and one micro-algae. These 35 micro-organisms identified by the European Food Safety Authority (EFSA) are either in the pre-commercialization phase or, in the case of a minority, already on the market. They have been genetically modified via protocols using new genetic modification […]

Analysis / Detection

Deregulation of GMOs: 13 organisations call for it to be rejected

Since its publication on 5 July 2023, the proposal to deregulate GMOs/NGTs has come up against significant opposition from many stakeholders. Farmers’, environmentalists’, farmers’, processors’ and consumers’ organisations, as well as supporters of organic farming, are mobilising to ensure that the proposal is rejected or at least amended. On 11 January 2023, the European Coordination […]

Innovation

Prophetic but misleading: fictitious examples in patents

The latest news on patents covering “biotechnological inventions”, particularly GMOs/NTGs, reminds us that these legal tools are above all long and complex texts. Yet the content of these texts determines the scope of these patents. In addition to a general description of the invention, including its industrial applications, a patent must describe one or more […]

Mutagenesis

French Anses experts : GMO deregulation has « no scientific basis »

Since September 2023, Member States and MEPs have been discussing the GMO deregulation proposal presented by the European Commission (EC) on July 5, point by point. In these discussions, the scientific basis of the proposed rules should be one of the points of attention. On this subject, the report by French experts of the Anses, […]

Sciences

The breeders’ gene pool: a semantic trap?

Does the European Commission master all the scientific jargon used in its proposed deregulation of GMOs? Are the multinationals trying to take advantage of the complexity of the scientific concepts involved to get more than they bargain for? The European legislator, whether a Member State government or an MEP, is, like most citizens, unaware of […]

Filter by year   :